Clinical Trial: Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma

Clinical Trial: Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma

Sponsor and Collaborators
Johannes Gutenberg University Mainz
Wyeth is now a wholly owned subsidiary of Pfizer
Mundipharma

Contact
Contact: Georg Hess, MD
00496131175040
georg.hess@unimedizin-mainz.de

Principal Investigator
Georg Hess, MD Department of Hematology, Oncology and Pneumology, Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany

ClinicalTrials.gov Identifier
NCT01078142